




Searching News Database: Nabi Biopharmaceuticals
HSMN NewsFeed - 29 Jul 2019
RenalytixAI Appoints Thomas McLain as President and Chief Commercial Officer
RenalytixAI Appoints Thomas McLain as President and Chief Commercial Officer
HSMN NewsFeed - 5 Jan 2015
Catalyst Pharmaceuticals Appoints David D. Muth, Executive Vice President, Chief Commercial Officer
Catalyst Pharmaceuticals Appoints David D. Muth, Executive Vice President, Chief Commercial Officer
HSMN NewsFeed - 13 Mar 2013
Vermillion Appoints Thomas McLain as President and Chief Executive Officer
Vermillion Appoints Thomas McLain as President and Chief Executive Officer
HSMN NewsFeed - 7 Nov 2011
Nabi Biopharmaceuticals Announces Results of Second NicVAX(R) Phase III Clinical Trial
Nabi Biopharmaceuticals Announces Results of Second NicVAX(R) Phase III Clinical Trial
HSMN NewsFeed - 16 Nov 2009
GSK and Nabi Announce Agreement for NicVAX(R), a Vaccine for Nicotine Addiction
GSK and Nabi Announce Agreement for NicVAX(R), a Vaccine for Nicotine Addiction
HSMN NewsFeed - 22 Jan 2008
Nabi Biopharmaceuticals Names Dr. Raafat E.F. Fahim as President and Chief Executive Officer
Nabi Biopharmaceuticals Names Dr. Raafat E.F. Fahim as President and Chief Executive Officer
HSMN NewsFeed - 4 Dec 2007
Biotest Pharmaceuticals Corporation Completes Acquisition of Nabi Biologics Business Unit
Biotest Pharmaceuticals Corporation Completes Acquisition of Nabi Biologics Business Unit
HSMN NewsFeed - 2 May 2007
Nabi Biopharmaceuticals Announces Positive Results of Phase IIb Trial of NicVAX
Nabi Biopharmaceuticals Announces Positive Results of Phase IIb Trial of NicVAX
HSMN NewsFeed - 16 Jan 2007
Nabi Biopharmaceuticals Announces Initiation of Civacir(R) Phase II 'Proof-of- Concept' Clinical Trial
Nabi Biopharmaceuticals Announces Initiation of Civacir(R) Phase II 'Proof-of- Concept' Clinical Trial
HSMN NewsFeed - 14 Nov 2006
Nabi Biopharmaceuticals Closes Sale of PhosLo(R) to Fresenius Medical Care
Nabi Biopharmaceuticals Closes Sale of PhosLo(R) to Fresenius Medical Care
HSMN NewsFeed - 16 Oct 2006
Nabi Biopharmaceuticals Announces Positive Results From PhosLo(R) EPICK Study
Nabi Biopharmaceuticals Announces Positive Results From PhosLo(R) EPICK Study
HSMN NewsFeed - 12 Oct 2006
Nabi Biopharmaceuticals Signs Definitive Agreement To Sell PhosLo(R) To Fresenius Medical Care
Nabi Biopharmaceuticals Signs Definitive Agreement To Sell PhosLo(R) To Fresenius Medical Care
HSMN NewsFeed - 12 Oct 2006
Fresenius Medical Care to Acquire Phosphate Binder Business from Nabi Biopharmaceuticals
Fresenius Medical Care to Acquire Phosphate Binder Business from Nabi Biopharmaceuticals
HSMN NewsFeed - 26 Sep 2006
Third Point LLC Announces Consent Solicitation to Remove Nabi Biopharmaceuticals Board Chairman
Third Point LLC Announces Consent Solicitation to Remove Nabi Biopharmaceuticals Board Chairman
HSMN NewsFeed - 29 Jun 2006
Nabi Biopharmaceuticals Secures Agreement with Kedrion to Co-Develop and Commercialize Civacir(R) in Europe
Nabi Biopharmaceuticals Secures Agreement with Kedrion to Co-Develop and Commercialize Civacir(R) in Europe
Additional items found! 47

Members Archive contains
47 additional stories matching:
Nabi Biopharmaceuticals
(Password required)
Nabi Biopharmaceuticals
(Password required)